Copyright
©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 7, 2007; 13(45): 5995-6002
Published online Dec 7, 2007. doi: 10.3748/wjg.v13.i45.5995
Published online Dec 7, 2007. doi: 10.3748/wjg.v13.i45.5995
Ulcerative colitis | |||
Normal | Inflamed | Uninflamed | |
No. of patients (cases) | 18 | 45 | 51 |
Sex (male/female) | 11/7 | 31/14 | 35/16 |
Age (yr), mean ± SD | 47.5 ± 20.1 | 35.3 ± 13.6 | 39.3 ± 14.1 |
Disease duration (yr) | 6.5 ± 6.6 | 6.2 ± 5.5 | |
Types of colitis | |||
Total | - | 31 | 10 |
Left-sided | - | 9 | 14 |
Proctitis | - | 0 | 24 |
Others | - | 5 | 3 |
Treatment | |||
Prednisolone (PSL) (no/yes) | - | 15/30 | 29/22 |
Azathioprine (AZA) (no/yes) | - | 31/14 | 42/9 |
- Citation: Shimamoto M, Ueno Y, Tanaka S, Onitake T, Hanaoka R, Yoshioka K, Hatakeyama T, Chayama K. Selective decrease in colonic CD56+ T and CD161+ T cells in the inflamed mucosa of patients with ulcerative colitis. World J Gastroenterol 2007; 13(45): 5995-6002
- URL: https://www.wjgnet.com/1007-9327/full/v13/i45/5995.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i45.5995